Cosmo Pharmaceuticals N.V. (LON:0RGI)
London
· Delayed Price · Currency is GBP · Price in CHF 68.20
+1.80 (2.71%)
At close: Feb 21, 2025
Cosmo Pharmaceuticals Revenue
Cosmo Pharmaceuticals had revenue of 136.24M EUR in the half year ending June 30, 2024, with 228.19% growth. This brings the company's revenue in the last twelve months to 185.36M, up 77.82% year-over-year. In the year 2023, Cosmo Pharmaceuticals had annual revenue of 92.78M, down -9.12%.
Revenue (ttm)
185.36M EUR
Revenue Growth
+77.82%
P/S Ratio
n/a
Revenue / Employee
570.33K EUR
Employees
325
Market Cap
962.51M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
| Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
| Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
| Dec 31, 2020 | 60.95M | -1.55M | -2.47% |
| Dec 31, 2019 | 62.50M | -3.12M | -4.76% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Cosmo Pharmaceuticals News
- 6 weeks ago - Cosmo Pharmaceuticals estimates 186% Y/Y growth in 2024 revenue - Seeking Alpha